| CAS: | 7327-87-9 | ||||||
| 分子式: | C8H12N6O4S | ||||||
| 分子量: | 288.28 | ||||||
| 沸点: | 648.3°C at 760 mmHg | ||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||
| D890513 | MACKLIN | 硫酸双肼屈嗪 | 98% | 126元/5mg; 534元/25mg; 1601元/100mg; 4000元/250mg; | 咨询 | ||||||||||||||||||||||||||||||||||||
储存:室温,保存在惰性气体中 | |||||||||||||||||||||||||||||||||||||||||
| C46623 | Alfa Aesar | Dihydralazine sulfate | 6129元/100mg; 11729元/250mg; | 咨询 | |||||||||||||||||||||||||||||||||||||
基本信息 Ref# 分子式 分子量 | |||||||||||||||||||||||||||||||||||||||||
| Y0000232 | Dihydralazine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1559.78元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||
| D2697 | Sigma-Aldrich | Dihydralazine sulfate | 4603.34元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||
产品说明 生化/生理作用 Dihydralazine sulfate is a vasodilator and an antihypertensive agent. It relaxes arterial smooth muscle by inhibiting the accumulation of intracellular free calcium. By relaxing vascular smooth muscle, vasodilators act to decrease peripheral resistance. 其他说明 Keep container tightly closed in a dry and well-ventilated place. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||
| 544243 | Fluorochem | 1,4-Dihydrazinylphthalazine sulfate | 98% | 5038元/250mg; 12584元/1g; | 咨询 | ||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||